Food Safety

HHS Secretary Tom Price signaled the administration may push to bring food safety under one roof in a speech to department staff Tuesday laying out a series of actions that will culminate in submission of a draft HHS-wide reform plan, which he dubbed “Reimagine HHS,” to the White House's budget office June 30.

FDA has delayed by one year implementation of the nationwide menu labeling rule that was set to go into effect May 5 in response to stakeholders' concerns and is asking for advice on how to rewrite the rule.

FDA Commissioner-nominee Scott Gottlieb said he is open to using new regulatory tools to demonstrate the agency's gold standard of safety and efficacy, and took a muted tone towards President Donald Trump's proposal to reopen FDA's negotiated user fee agreements and the administration's support for Right to Try legislation in his answers to more than 60 written questions from Senate health committee ranking Democrat Patty Murray (WA).

FDA this week signed its third international food safety pact -- recognizing Australia's system as comparable to that of the U.S. after having signed similar agreements with Canada and New Zealand -- and now turns its attention to the EU, an agency spokesperson told Inside Health Policy.

FDA plans to dissolve its regional food and drug director functions and set up six new positions in charge of commodity-based programs as part of a Program Alignment Initiative launched in 2013.

Newly confirmed CMS chief Seena Verma and FDA chief-nominee Scott Gottlieb, if confirmed, face immediate orders from the White House to craft plans to reorganize their agencies to improve efficiency, shift functions to the states or local governments, and merge or shut down any functions for which costs aren't justified by public benefits or are redundant with work of other agencies.

Congress' investigative arm is calling on the Trump White House to develop a national strategy to coordinate food safety oversight, which now spans across 16 federal agencies and 30 federal laws, saying in a recent report that a similar request made six years ago to the Obama White House fell flat.

President Donald Trump put heads of executive departments and agencies on notice that no new rules or guidances should be sent to the Office of the Federal Register (OFR) until a Trump-appointed or designated agency head reviews and approves them, potentially putting controversial FDA draft guidances and notices on such hot-button issues as off-label use, new dietary ingredients, compounding and biosimilars on hold.

House Republicans are planning to vote on a set of bills this week that would increase Congress' ability to roll back rules passed in the final 60 legislative days of President Barrack Obama's administration, and pledged to dedicate much of the next two months toward overturning administrative rules finalized by the Obama administration.